Acura Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Cash & Equivalents	0.07	0.41	0.86	0.09	2.22
Cash & Short-Term Investments	0.07	0.41	0.86	0.09	2.22
Cash Growth	-84.26%	-52.09%	847.25%	-95.90%	-17.20%
Accounts Receivable	0.16	0.63	0.16	0.14	0.07
Other Receivables	-	-	0.03	0.07	-
Receivables	0.16	0.63	0.19	0.2	0.07
Prepaid Expenses	0.15	0.14	0.12	0.17	0.28
Total Current Assets	0.37	1.18	1.18	0.46	2.57
Property, Plant & Equipment	0.49	0.48	0.54	0.61	0.68
Other Intangible Assets	-	0.07	0.81	1.02	1.22
Other Long-Term Assets	-	-	0.03	0.07	0.14
Total Assets	0.86	1.74	2.56	2.15	4.6
Accounts Payable	0.19	0.03	0.24	0.61	0
Accrued Expenses	0.24	1.31	0.59	0.6	1.64
Current Portion of Long-Term Debt	-	6.16	-	-	2.69
Current Portion of Leases	0.03	-	-	-	-
Other Current Liabilities	0.05	0.02	0.25	0.23	0.3
Total Current Liabilities	0.52	7.52	1.07	1.44	4.63
Long-Term Debt	0.15	0.11	6	4.22	-
Long-Term Leases	0.02	-	-	-	-
Other Long-Term Liabilities	-	-	0.23	0.11	-
Total Liabilities	0.68	7.63	7.3	5.77	4.63
Common Stock	0.65	0.22	0.21	0.21	0.21
Additional Paid-In Capital	389.61	383.1	383.04	380.4	380.15
Retained Earnings	-390.08	-389.2	-388	-384.22	-380.38
Shareholders' Equity	0.18	-5.89	-4.74	-3.62	-0.03
Total Liabilities & Equity	0.86	1.74	2.56	2.15	4.6
Total Debt	0.2	6.27	6	4.22	2.69
Net Cash (Debt)	-0.14	-5.86	-5.14	-4.13	-0.47
Net Cash Per Share	-0.00	-0.18	-0.19	-0.20	-0.03
Filing Date Shares Outstanding	66	22.1	21.65	21.3	20.8
Total Common Shares Outstanding	65.09	21.65	21.3	21.03	20.8
Working Capital	-0.14	-6.34	0.1	-0.97	-2.07
Book Value Per Share	0.00	-0.27	-0.22	-0.17	-0.00
Tangible Book Value	0.18	-5.96	-5.55	-4.63	-1.25
Tangible Book Value Per Share	0.00	-0.28	-0.26	-0.22	-0.06
Land	0.16	0.16	0.16	0.16	0.16
Buildings	1.27	1.27	1.27	1.27	1.27
Machinery	1	1	1	1.01	1.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.